|Status : Published||Published On : Feb, 2022||Report Code : VRHC1256||Industry : Healthcare||Available Format :||Page : 200|
The global aseptic pharma processing equipment market is anticipated to grow from USD 7.91 billion in 2021 and reach USD 15.75 billion by 2027, exhibiting a compound yearly growth rate of 7.1 percent (CAGR). The processing of pharmaceuticals is the technique of drug manufacturing which includes a range of unit operations like milling, granulation, blending, tablet pressing, coating, filling, sealing, packaging and others. In terms of quality, the pharmaceutical manufacturing process includes certain standards and manufacturing norms. Thus, it's imperative that pharmaceutical manufacturing equipment adheres to good manufacturing practices (GMP). Aseptic pharma processing equipment is a commercially available technology for thermally sterilizing formulations (liquid or powder) for packaging into previously sterilized containers under sterile conditions to generate shelf-stable, non-refrigerable products. The increased use of robotics for automating specific processing and packaging of pharmaceutical products, increased healthcare expenditure, favorable government regulations, and rising investment by pharmaceutical companies for bulk manufacturing will drive the growth of the market.
The COVID-19 outbreak has substantially impacted the global aseptic pharma processing equipment market as manufacturing processes were slowed down, difficulty in the supply of raw material, travel bans. The COVID-19 situation has had an impact on the production of systems and consumables used in aseptic pharma processing equipment procedures, as companies have been urged to develop testing kits, repaid detection assays, drugs, and vaccines so as to decrease the spread of the deadly coronavirus disease.
Insight by Component
The worldwide aseptic pharma processing equipment market is divided into processing and packaging equipment based on component. The processing equipment is further divided into drying equipment, extruders, mills, granulation equipment, tablet compression equipment, feeders, fill/finish equipment, mixing equipment, and pneumatic conveying equipment. The packaging equipment is further divided into inspection machines, labeling machines, and aseptic packaging machines. The aseptic processing equipment dominates the market owing to increased demand, associated high cost per unit, and is used to manufacture any drug i.e., solid or liquid in a sterile environment. Furthermore, aseptic pharmaceutical processing is the procedure for drug manufacture and can be broken into a wide range of operations which includes blending, granulation, milling, coating, tablet pressing, filling, and others. In terms of quality, the aseptic pharmaceutical production process includes certain needs and manufacturing norms. As a result, pharmaceutical businesses are required to follow excellent manufacturing processes.
Insight by Application
On the basis of application, the global aseptic pharma processing equipment market is segregated into ophthalmic suspensions, reconstituted lyophilized powders for injection, sterile injectables, aqueous-based aerosols for inhalation, and others. The ophthalmic suspension dominates the aseptic pharma processing equipment market as the ophthalmic products are intended for use on the conjunctiva or eyelids and contain at least one active pharmaceutical ingredient. Because the risks of microbiological content or bio-burden in raw materials are very high, aseptic pharma processing becomes extremely important. As a result, the worldwide aseptic pharma processing equipment market will benefit from this use.
Aseptic Pharma Processing Equipment Market Report Coverage
Base Year Considered
Market Size in 2021
Revenue Forecast in 2027
Segments Covered in the Report
By Component and By Application
Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Impact of COVID-19; Companies’ Strategic Developments; Market Share Analysis of Key Players; Company Profiling
Regions Covered in the Report
North America, Europe, Asia-Pacific, Middle East, and Rest of the World
The increased demand by contract manufacturing organizations (CMOS) for aseptic manufacturing of pharmaceutical products, mounting development in the pharmaceutical industry is the key trends in the global aseptic pharma processing & packaging equipment market.
Factors attributing to the growth of the aseptic pharma processing equipment market include increased adoption of automation technologies so as to reduce cost and increase productivity, safety and solve hygiene-related problems, to develop specific drugs, increased demand from generics, and biopharmaceuticals markets,. Furthermore, the mounting demand for generics and biopharmaceutical markets, reduced risk of high-cost product loss, increased healthcare expenditure, rising prominence of chronic diseases, and the advent of new drugs will drive the growth of the market.
Lack of skilled personnel having the technical knowledge to set up manufacturing plants for aseptic pharma processing increased the cost of aseptic processing equipment, and preference for refurbished equipment due to high investment in aseptic processing equipment may pose challenges for the growth of the aseptic pharma processing equipment market.
The growing elderly population, high prevalence of infectious diseases, and increased focus on targeted therapy have all contributed to a significant increase in pharmaceutical sales in recent years. Pharmaceutical product growth has been spurred by increased global demand for drugs. With an increase in research and clinical trials undertaken by pharmaceutical producers, productivity has improved in the pharmaceutical manufacturing industry. Furthermore, the COVID-19 pandemic has heightened pharmaceutical companies' efforts to create effective medications and vaccines to combat SARS-CoV virus infection. Establishing effective processes and workflows to lower the costs and time required in drug and vaccine development has become increasingly important in this environment. Thus, escalating R&D investment by pharmaceutical manufacturers will favor the growth of the aseptic pharma processing equipment market.
North America dominates the aseptic pharma processing equipment market owing to standardized regulatory measures for sterilization of pharmaceuticals, improvement in healthcare infrastructure, and many companies providing aseptic processing. Moreover, significant investment by biotechnology companies to enhance their manufacturing facilities and developed automation technologies, increased per capita income will accelerate the growth of the market.
Europe is anticipated to grow at a significant pace owing to the presence of a large number of contract drug manufacturers (CDMOs) and increased demand for aseptic processing in European countries will further accelerate the growth of the region. Furthermore, Germany and Denmark are the biggest exporters of drugs and medicine, driving the growth of the aseptic pharma processing equipment market.
There is a lot of competition in the aseptic pharmaceutical processing and packaging equipment market, but the product differentiation is less. The significant increase in demand for biopharmaceuticals like vaccines and other treatments has resulted in an expansion in aseptic processing facilities for standardized pharmaceutical manufacturing. Furthermore, as the number of CDMOs has grown, specific aseptic processing technologies are increasingly adopted. Major strategies have been included by companies such as Baxter International to expand their market presence through crucial innovations.
When it comes to divesting from their enterprises, players are hesitant. Furthermore, because there is a significant amount of money at stake, the exit barriers are somewhat high. As a result, the level of competitiveness is moderate to high. Nevertheless, strategies adopted by the global aseptic pharma processing equipment market include mergers and acquisitions, partnerships, and collaborations, and the launch of new products.
ILC Dover is a prominent provider of powder containment solutions to pharmaceutical companies across the world. Their developed solutions have been shown to increase productivity and reduce capital and cleaning costs while maintaining the safety and dependability of the containment solutions. Pharmaceutical businesses can secure their operators while developing highly potent APIs with single-use flexible powder process and containment solutions. Their recent acquisition of Solo Containment has broadened ILC Dover high containment and powder transfer solutions to include aseptic flexible isolators and other flexible film containment isolators, allowing them to target niche HPAPI applications in pharmaceutical manufacturing.
For the pharmaceutical processing business, SPX FLOW produces dedicated mixing, heat transfer, pneumatic, and dehydration systems. To develop highly specialized pharmaceutical processes, they have experience, offer a global network of research and development centers, and a dedicated group of knowledgeable application engineers. SPX FLOW is a custom heat transfer system developer and manufacturer for the pharmaceutical manufacturing sector. SPX FLOW creates custom-fit heat exchangers by first learning about the product and the demands of the customer. SPX FLOW provides customised mixer design services to tailor a mixer to the needs of the customer. The worldwide mixing lab of SPX FLOW in Rochester, New York, is a scientific testing environment where SPX FLOW brands Lightnin and Plenty research mixing solutions using cutting-edge predictive technologies.
In July 2021, SP Scientific Products (SP) has added two new entirely GMP compliant loading options for SP Hull LyoConstellationTM freeze dryers to its freeze dryer loader line. SP's latest loader launches, which are designed for advanced aseptic pharmaceutical processes including lyophilization, provide versatile and creative solutions for small to medium batch and high-speed full line aseptic vial handling applications.
The soloPURE flexible aseptic isolator was introduced in April 2021 by ILC Dover, a company that specializes in the design and manufacture of single-use flexible solutions for global pharmaceutical and biopharmaceutical processing. The new product is a low-cost, closed-barrier sterile manufacturing system. SoloPURE is the future of sterile manufacturing, with a fully disposable, single-use chamber and a CAPEX-efficient compact design.
Some of the key players in the aseptic pharma processing equipment market include SP Industries, Inc., Robert Bosch GmbH, ILC Dover LP, Dupont, Rommelag Kunststoff-Maschinen Vertriebsgesellschaft mbH, SPX Flow, Inc., Becton, Dickinson, and Company, Amcor plc, GEA Group Aktiengesellschaft, and JBT.
To explore more about this report - Request a free sample copy
The Aseptic Pharma Processing Equipment Market report offers a comprehensive market segmentation analysis along with an estimation for the forecast period 2021–2027.
Segments Covered in the Report
• By Component Type
- Processing Equipment
> Drying Equipment
> Extruders, Mills
> Granulation Equipment
> Tablet Compression Equipment
> Fill/Finish Equipment
- Mixing Equipment
> Pneumatic Conveying Equipment
> Packaging Equipment
> Inspection Machines
> Labeling Machines
> Aseptic Packaging Machines
• By Application
> Ophthalmic Suspensions
> Reconstituted Lyophilized Powders for Injection
> Sterile Injectables
> Aqueous-Based Aerosols for Inhalation
Region Covered in the Report
• North America
- Rest of Europe
• Asia-Pacific (APAC)
- South Korea
- Rest of Asia-Pacific
• Rest of the World (RoW)
- Saudi Arabia
- South Africa
- Other Countries